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ABSTRACT
Delineating the signaling pathways that underlie ESC plu-
ripotency is paramount for development of ESC applica-
tions in both the research and clinical settings. In culture
pluripotency is maintained by leukemia inhibitory factor
(LIF) stimulation of two separate signaling axes: Stat3/
Klf4/Sox2 and PI3K/Tbx3/Nanog, which converge in the
regulation of Oct4 expression. However, LIF signaling is
not required in vivo for self-renewal, thus alternate signal-
ing axes likely mediate these pathways. Additional factors
that promote pluripotency gene expression have been iden-
tiﬁed, including the direct regulation of Oct4 by liver re-
ceptor homolog-1 (Lrh-1) and b-catenin regulation of
Nanog. Here, we present genetic, molecular, and pharma-
cological studies identifying a signaling axis in which
b-catenin promotes pluripotency gene expression in an
Lrh-1-dependent manner. Furthermore, Lrh-1 was identi-
ﬁed as a novel b-catenin target gene, and Lrh-1 regulation
is required for maintaining proper levels of Oct4, Nanog,
and Tbx3. Elucidation of this pathway provides an alter-
nate mechanism by which the primary pluripotency axis
may be regulated in vivo and may pave the way for small
molecule applications to manipulate pluripotency or
improve the efﬁciency of somatic cell reprogramming.
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INTRODUCTION
The Oct4/Sox2/Nanog pluripotency axis has consistently been
reiterated as the central pathway mediating ESC pluripotency
and self-renewal and more recently in reprogramming somatic
cells into induced pluripotent stem cells in both the mouse
and human model system [1–5]. Standard methods for main-
taining mouse ESC (mESC) self-renewal require supplement-
ing media with the growth factor leukemia inhibitory factor
(LIF), which acts through the receptor gp130, to stimulate
two parallel pathways: Stat3/Klf4/Sox2 and PI3K/Tbx3/Nanog
[6]. However, recent ﬁndings report that mESC have an
innate program directing self-renewal independent of extrinsic
factors, and that suppression of differentiation cues is sufﬁ-
cient to maintain pluripotency [7]. This ﬁnding is consistent
with genetic models, which report that LIF-signaling is dis-
pensable for self-renewal in vivo [8, 9]. Similarly, LIF stimu-
lation does not support self-renewal in human ESC culture
[10]. This suggests that alternate mechanisms regulate these
signaling axes in vivo. Several ‘‘secondary pluripotency fac-
tors’’ have been identiﬁed which are thought to be important
for regulating ESC self-renewal, as well as maintaining stem
cell identity during development [11, 12]. Among them, the
nuclear receptors Esrrb/Nr3b2, Dax-1/Nr0b1, and liver
receptor homolog-1 (Lrh-1)/Nr5a2 have been reported to
comprise secondary pluripotency regulation, however, these
studies are limited in that they focus on Oct4 regulation alone
or do not report a clear mechanism [11–14].
Previously we reported that the orphan nuclear receptor,
Lrh-1, is essential for maintaining Oct4 expression at the epi-
blast stage of embryonic development, and that genetic abla-
tion causes embryonic lethality around 6.0–7.0 days postcoi-
tum (dpc) [12]. This was supported by observations in mESC
that Lrh-1 promotes Oct4 expression directly by binding evo-
lutionary conserved elements in the proximal promoter (PP)
and proximal enhancer (PE). However, Lrh-1 is not required
for formation of the inner-cell mass, and Lrh-1
-/- ESC main-
tain expression of Oct4. Thus, Lrh-1 is not essential for main-
taining ESC self-renewal, but rather is principal in regulating
Oct4 expression during early differentiation [12].
Others have implicated Lrh-1 as a central factor governing
the self-renewal of intestinal crypt cells by forming a complex
with b-catenin [15]. The ubiquitous Wnt signaling pathway
plays myriad roles in development and disease [16]. Canoni-
cal Wnt signaling drives self-renewal in the gut and the hema-
topoietic system making it an enticing mechanism to study in
regard to ESC self-renewal [17–19]. Similar to the phenotype
observed in the Lrh-1 null mice, b-catenin null mice fail to
gastrulate and die at approximately E6.0 [20]. b-catenin is not
required for formation of the inner-cell mass, but is reportedly
important in specifying cell fate in the pregastrulation embryo
[20, 21]. b-catenin is known to mediate differentiation,
namely brain formation and mesoderm speciﬁcation [20–24],
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maintaining pluripotency [25, 26]. Among them, the observa-
tion that stabilizing b-catenin through inhibition of glycogen
synthase kinase-3 (GSK3) using the small molecule inhibitor
6-bromoindirubin-30-oxime (BIO) is sufﬁcient to maintain
self-renewal in both mouse and human ESC [27]. In support
of this is the ﬁnding that b-catenin promotes pluripotency by
forming a complex with Oct4 that drives Nanog expression,
and that stabilized b-catenin permits LIF-independent self-
renewal [28].
To investigate deﬁnitively the role of canonical Wnt sig-
naling in the regulation of pluripotency, we generated b-cate-
nin
-/- ESC. Although exhibiting defects in differentiation, the
b-catenin
-/- ESCs maintain expression of pluripotency genes,
albeit at decreased levels, and serve as a stringent control for
molecular studies. Among those, we observe that Lrh-1
expression is induced on stimulation of Wnt signaling using
molecular and pharmacological methods, and induction occurs
in a b-catenin-dependent manner. Furthermore, Wnt induction
of pluripotency factors is both b-catenin and Lrh-1 dependent.
We report that b-catenin regulates Lrh-1 directly via con-
served lymphoid enhancer factor (LEF)/T-cell factor (TCF)
sites in the full-length and embryonic stem (ES) speciﬁc pro-
moters of Lrh-1 [29], allowing for subsequent Lrh-1 regula-
tion of Tbx3, Nanog, and Oct4. Finally, ectopic expression of
Lrh-1 in b-catenin
-/- ESC is sufﬁcient to restore Oct4 and
Nanog expression to wt levels.
By implementing a genetic approach in the ESC model,
we have revealed a secondary pluripotency axis driven by ca-
nonical Wnt regulation of Lrh-1. Elucidation of this pathway
extends our bourgeoning understanding of the molecular sig-
nature of pluripotency, and may prove applicable to reprog-
ramming and other ESC applications.
MATERIALS AND METHODS
Derivation of b-Catenin
-/- ES Cells
b-catenin
ﬂox/ﬂox male mice (Jackson Laboratories, Bar Harbor, ME,
http://www.jax.org) were crossed with transgenic females expressing
Cre-recombinase driven by the Zona Pelucida protein-3 (ZP3)p r o -
moter (Jackson Laboratories) triggering an early recombination event
[22, 30–32]. b-catenin
þ/ﬂox, ZP3-Cre/
þ females were derived and
backcrossed to wt males to yield b-catenin
-/þ offspring. Resultant b-
catenin
-/þ offspring were isolated and maintained in a colony (Fig.
1A). b-catenin heterozygote mice were bred and blastocysts isolated
at 3.5 dpc. ESC lines were derived by blastocyst outgrowth as previ-
ously described [12].
Figure 1. b-catenin promotes pluripotency gene expression mouse ESC. (A): Breeding schematic for the generation of b-catenin
6 mice and b-catenin
-/-
ES cells. Embryos were isolated at E3.5 from a heterozygote cross and individually cultured in vitro, so ES cell lines could be derived by blastocyst out-
growth. (B): Western blot analysis for the expression of b-catenin, Oct4, and Nanog in undifferentiated wt and b-catenin
-/- ESC. b- a c t i nw a sp r o b e da sa
loading control. (C): qRT-PCR analysis of Oct4, Nanog, Lrh-1, and b-catenin expression in wt and b-catenin
-/- ESC on embryoid body differentiation. *, p
< .05; **, p < .01; ***, p < .001. (D): Western blot analysis of Oct4, Nanog, Lrh-1, and b-catenin expression in wt and b-catenin
-/- ESC on differentiation
with retinoic acid. b-actin was probed as a loading control. (E): qRT-PCR analysis of Oct4, Nanog, and Lrh-1 expression in wt ESC on inhibition of the ca-
nonical Wnt signaling pathway with increasing concentration (1 ng–250 ng/ml) of recombinant Dkk-1 in the absence of leukemia inhibitory factor. Abbrevi-
ation: qRT-PCR, quantitative reverse transcribed-polymerase chain reaction; wt ES, wild type embryonic stem.
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DNA was extracted from ES cell lines and mouse tails after over-
night digestion in lysis buffer (0.5% sodium dodecyl sulfate, 50
mM Tris pH 7.5, 0.1 M NaCl, 5 mM EDTA, 0.2 mg/ml protein-
ase K), followed by phenol/chloroform/isoamyl alchohol extrac-
tion (Invitrogen, Carlsbad, CA, http://www.invitrogen.com). Gen-
otyping was performed using the following speciﬁc primers for
the b-catenin locus: RM41: 50-AAGGTGGAGTGATGAAA-
GTTGTT-30, RM42: 50-CACCATGTCCTCTGTCTATTC-30, and
RM43: 50-TACA CTATTGAATCACAGGGACTT-30 [22].
Cell Culture, In Vitro Differentiation, and Small
Molecule Treatments
ES cell lines were maintained on plates treated with 0.1% gelatin
(Sigma, St. Louis, MO, http://www.sigmaaldrich.com), under
standard conditions described previously [12]. ES cell lines were
differentiated by withdrawal of LIF from ESC media and addition
of 1 lM all-trans-retinoic acid (RA; Sigma). Embryoid body dif-
ferentiation was carried out by forming the aggregates in low-
attachment plates (25,000 cells/ml) or by hanging drop (500
cells/20 microl drop) for 3 days prior to transferring the embry-
oid bodies to gelatinized plates. ESC lines were treated with 2
microM BIO (Calbiochem, Darmstadt, Germany, http://
www.emdchemicals.com) reconstituted in dimethyl sulfoxide
(DMSO) or 100 ng/ml mWnt3a (R&D Systems, Minneapolis,
MN, http://www.rndsystems.com/). Recombinant Dickkopf-1
(Dkk-1; R&D Systems) was added at increasing concentrations
from 1 ng/ml to 250 ng/ml. CHIR99021 (Stemgent, San Diego,
CA, http://www.stemgent.com) was added at an increasing con-
centration (10 nM, 100 nM, 1 microM, 2.5 microM, and 5 micro
M). All treatments were performed in the absence of LIF.
Transient Transfection and Plasmids
The Lrh-1 promoter regions were generously provided by You-
Hua Xie [29] and were transfected alongside the TOP-FLASH re-
porter (Upstate, Billerica, MA, http://www.millipore.com) under
the following conditions: 125,000 ESCs were transfected in sus-
pension with 100 ng of reporter, 2 ng of Renilla luciferase
expression vector (Promega, Madison, WI, http://www.promega.
com), using 2.5 microl Lipofectamine 2000 (Invitrogen), and
plated in single well of a 12-well plate. Each transfection was
assayed in triplicate. Promoter activity was measured using a
Berthold Centro LB960 dual-luciferase luminometer and recorded
in relative light units after normalizing to Renilla luciferase.
Immunoﬂuorescence and Western Blot
Antibody information and conditions are listed in (Supporting In-
formation Table 1). Western Blot analysis was performed under
standard denaturing conditions.
Quantitative Reverse Transcription Polymerase
Chain Reaction (qRT-PCR) Analysis
Total RNA was extracted from ES cells using Trizol reagent
(Invitrogen). cDNA was generated using the Super Script III First
Strand Synthesis Kit (Invitrogen) with Oligo dT primers follow-
ing the manufacturer’s protocol. Quantitative expression of en-
dogenous genes was carried out using QuantiFast SYBR Green
PCR (Qiagen, Valencia, CA, http://www.qiagen.com) on a Step 1
Plus Real Time PCR System (Applied Biosystems, Carlsbad, CA,
https://products.appliedbiosystems.com). Target gene expression
was normalized to b-actin expression in all experiments. For
gene-speciﬁc primers see Supporting Information Table 2.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) assays were performed
following a protocol modiﬁed from previous reports [12, 33]. Un-
differentiated wt and b-catenin
-/- ESCs were treated for 6 hours
with 2 microM BIO or differentiated for 2 days with 1 microM
RA prior to ﬁxation with 1.1% formaldehyde. Cross-linked DNA
underwent enzymatic shearing using the ChIP-IT Express Enzy-
matic kit (Active Motif, Carlsbad, CA, http://www.activemotif.
com) following the manufacturers protocol. Lysate protein con-
centration was determined postshearing and lysates diluted to
0.25 microg/microl. For antibody information and immunopreci-
pitation conditions see (Supporting Information Table 1). Recov-
ered DNA was quantitatively ampliﬁed with gene-speciﬁc primers
spanning the putative LEF/TCF sites using QuantiFast SYBR
Green PCR (Qiagen) and normalized to 10% input. For ChIP
primer sequences see Supporting Information Table 3.
Teratoma Formation
Teratomas were generated from wt and Lrh-1
-/- ESC after injec-
tion of approximately 10
6 cells into the hind-quarters of nude
SCID mice. Histological analysis was carried out on teratoma
sections after standard H&E staining.
Generation of Myc-Tagged Lrh-1 b-Catenin
-/-
Stable Cell Line
The previously described embryonic isoform of Lrh-1 was cloned
into a pCMV-myc expression vector (Clontech) using PCR primers:
forward 50-TCGAATTCTCATGCTGCCCA AAG TGGAG-30 and
reverse 50-TAGTCGACTTAGGCTCTT TTGGCATGCAGCA-30
[29]. Myc-tagged Lrh-1 was then subcloned into the pEF1a-ORF-
IRES-neo vector described in with PCR primers: forward 50-
TCGCTAGCATGGCA TCAA TGCAGAAGCT-30, and reverse 50-
TCGCGGCCGCTTAGG CTCTTTTGGCATGCA-30 [33]. The
pEF1a-mycLrh1(ES)-IRES-neo vector was targeted into the b-cate-
nin
-/- ESCs via electroporation (25 microg linearized vector/
10,000,000 cells). Heterologous recombinants were screened by
selection with G418 for approximately 10 days, and clonal resistant
ES colonies were isolated and expanded in culture.
Statistical Analysis
Statistical signiﬁcance was determined by performing two-tailed
t-tests where appropriate.
RESULTS
Generation and Characterization of b-Catenin
-/- ESC
To evaluate the role of canonical Wnt signaling in ESC pluri-
potency, b-catenin
-/- ESC were derived by blastocyst out-
growth following a germline Cre-lox recombination event
yielding heterozygous mice [22] (Fig. 1A). Western blot anal-
ysis conﬁrms the absence of b-catenin protein in the mutant
cell line, however, Oct4 and Nanog are expressed (Fig. 1B).
Although b-catenin
-/- ESC express these pluripotency factors,
they are not pluripotent insofar as they exhibit pronounced
defects in endoderm and mesoderm induction on embryoid
body differentiation (Supporting Information Fig. 1). Further-
more, two separate attempts at forming teratomas with the b-
catenin
-/- ESC yielded no detectable tumors. These ﬁndings
are consistent with the phenotype of the b-catenin
-/- mouse,
which exhibits a gastrulation defect in vivo [20]. Neverthe-
less, in culture, the program for self-renewal and the expres-
sion of pluripotency factors is intact making the b-catenin
-/-
ESC a useful tool for studying canonical Wnt signaling in wt
mESC.
Proper expression of pluripotency factors is paramount for
ESC self-renewal [34], so b-catenin
-/- ESC were characterized
on differentiation by embryoid body formation as well as on
treatment with RA. Oct4 and Nanog exhibit signiﬁcant misex-
pression in b-catenin
-/- ESC (Fig. 1C) and are more rapidly
silenced on RA-mediated differentiation, which is apparent at
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Lrh-1 is expressed at basal levels in b-catenin
-/- ESC and is
nonresponsive to RA treatment (Fig. 1D and Supporting Infor-
mation Fig. 2), indicating that Lrh-1 is misregulated in the b-
catenin
-/- ESC. Genetically, this casts Lrh-1 as a putative b-
catenin target gene.
To support this ﬁnding, we employed a nongenetic
approach to inhibit canonical Wnt signaling by treating wt
ESC with recombinant Dkk-1. Dkk-1 is a secreted factor
that prevents the association of Frizzled and Lrp5-6, a
necessary step in the stabilization of b-catenin [35].
Oct4, Nanog, and Lrh-1 exhibit dose-dependent repression
on treatment with Dkk-1 (Fig. 1E). The observation that
Dkk-1 treatment is sufﬁcient to repress pluripotency gene
expression provides independent conﬁrmation of the defect
in pluripotency gene expression observed in the b-catenin
-/-
ESC.
Lrh-1 Is Induced in a b-Catenin-Dependent
Manner
In contrast to Dkk1 treatment, we sought to determine the
effects of promoting canonical Wnt signaling in ESC. Promot-
ing b-catenin stabilization with BIO, a pharmacological
Figure 2. Canonical Wnt regulation of Lrh-1 expression is b-catenin dependent. (A): qRT-PCR analysis of Lrh-1 expression on treatment with
BIO. Wt (upper graph) and b-catenin
-/- ESC (lower graph) treated with BIO or DMSO vehicle in the absence of LIF. **, p < .01. (B): Treatment
of wt ESC with recombinant Wnt proteins. Lrh-1 expression was examined in undifferentiated ESC treated with increasing concentration of
Wnt3a or Wnt5a in the absence of LIF. **, p < .01. (C): qRT-PCR analysis of Lrh-1 expression in wt and b-catenin
-/- ESC treated with recombi-
nant Wnt3a for 24 hours in the absence of LIF. *, p < .05; **, p < .01. (D): Luciferase reporter assay of Lrh-1 promoter constructs. Wt and b-
catenin
-/- ESC were transiently transfected with reporters for the Lrh-1 full-length promoter, the Lrh-1 ES promoter, and truncations of the ES
promoter causing loss of putative LEF/TCF sites (denoted as arrows). Reporter activity was then measured in cells treated with LIF, RA, or BIO
for 24 hours. *, p < .05. (E): In vitro analysis of b-catenin transcriptional activity in wt and b-catenin
-/- ESC using the TOP-FLASH reporter on
treatment with LIF, RA, or BIO. *, p < .05. Abbreviations: BIO, 6-bromoindirubin-30-oxime; DMSO, dimethyl sulfoxide; LEF, lymphoid
enhancer factor; LIF, leukemia inhibitory factor; qRT-PCR, quantitative reverse transcribed-polymerase chain reaction; RA, retinoic acid; RLU,
relative light unit; TCF, T-cell factor; wt ES, wild type embryonic stem; wt mES, wild type mouse embryonic stem.
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Lrh-1 expression that was maintained for 5 days (Fig. 2A,
upper graph). This effect was b-catenin-dependent, as no
response was observed in the b-catenin
-/- ESC (Fig. 2A, lower
graph). Additionally, b-catenin-dependent induction of Lrh-1
was recapitulated on treatment with CHIR99021, an alternate
GSK3 inhibitor that is a component of the (2i/3i) GSK3/mito-
gen activated protein kinase Kinase (MEK) inhibitor cocktails
that are reported to drive ground state pluripotency independ-
ent of LIF [7] (Supporting Information Fig. 3).
The moderate speciﬁcity that BIO has for GSK3 and the
fact that GSK3 has other targets besides b-catenin led us to
seek additional evidence to implicate canonical Wnt signaling
in Lrh-1 induction [36, 37]. Wnt stimulation was investigated
as well by supplementing media with recombinant Wnt3a and
Wnt5, regarded as ‘‘canonical’’ and ‘‘noncanonical’’ Wnts,
respectively [38, 39]. Although Wnt3a triggered a signiﬁcant
dose-dependent induction of Lrh-1, the noncanonical Wnt5a
yielded only a modest induction that was not dose-dependent
(Fig. 2B). Furthermore, Lrh-1 is induced in a b-catenin-de-
pendent manner on stimulation with Wnt3a conﬁrming that
Lrh-1 is a novel target of the canonical Wnt signaling path-
way (Fig. 2C). Wnt stimulation fully recapitulates the effects
observed on GSK3 inhibition and validates BIO as a useful
modulator of the pathway in our system.
Lrh-1 Is a Direct Target of b-Catenin in mESC
LEF/TCF transcription factors mediate Wnt induced changes
in gene expression through an interaction with nuclear b-cate-
nin [16]. The murine Lrh-1 gene contains an embryonic stem
cell speciﬁc (ES) isoform driven by an alternate promoter
downstream of the full-length (FL) promoter [29]. In silico
analysis of each promoter region identiﬁed multiple LEF/TCF
consensus sites (A/T A/T CAAAG) within each promoter
[40]. Reporter constructs spanning these regions and described
previously were transfected into wt and b-catenin
-/- ESC to
compare activity [29]. Although the Lrh-1 FL promoter exhib-
its basal activity in both cell lines, the 1.4 kb ES promoter
revealed signiﬁcantly higher activity in wt cells compared
with the mutant cell line, which was suppressed on differen-
tiation with RA, and induced in a b-catenin-dependent manner
on BIO treatment (Fig. 2D). Transfecting serial truncations of
the ES promoter yielded decreased activity, and proved less
responsive to BIO implying that the putative LEF/TCF sites
identiﬁed are important for activity in vitro. The decreased ac-
tivity and blunted response to BIO in b-catenin
-/- ESC closely
mirrored TOP-FLASH activity [41] (Fig. 2E). Interestingly,
TOP-FLASH activity is not signiﬁcantly repressed on RA
treatment in wt ESC. This is in contrast to the repressed activ-
ity observed on RA treatment in cells transfected with the 1.4
kb ES-speciﬁc Lrh-1 reporter, and may be due to promoter
speciﬁc effects.
To determine if Lrh-1 induction is a primary effect of b-
catenin stabilization, ChIP against b-catenin was performed.
Of the eight putative LEF/TCF sites identiﬁed in the Lrh-1
promoter the highest degree of evolutionary conservation was
observed at sites proximal to transcription start site in each
promoter, here named: Ts(FL)-1, Ts(FL)-2, Ts(ES)-1, and
Ts(ES)-2 (Fig. 3A). We therefore investigated these regions
for b-catenin binding. Wild-type and b-catenin
-/- ESC were
treated with BIO for 6 hours before ﬁxation to ensure that
only the immediate transcriptional effects of b-catenin would
be assayed, whereas RA-treated cells were ﬁxed after 2 days
of treatment to reﬂect a differentiated ES cell. In the LIF-
treated undifferentiated ESC, b-catenin exhibited little enrich-
ment in both the FL and ES-speciﬁc Lrh-1 promoter, how-
ever, LEF/TCF sites: Ts(FL)-1, Ts(ES)-1, and Ts(ES)-2
became highly enriched after treatment with BIO (Fig. 3B).
b-catenin enrichment at Ts(FL-2) exhibited negligible enrich-
ment on each treatment, implying that Ts(FL)-2 may be irrel-
evant in mediating b-catenin regulation of Lrh-1. Any enrich-
ment of b-catenin is lost on RA differentiation suggesting that
the direct regulation of Lrh-1 by b-catenin is not a character-
istic of RA-mediated differentiation. In controls for the ChIP,
enrichment of b-catenin was observed at the Axin2 promoter
after BIO treatment [42], whereas enrichment at an off-target
Lrh-1 intronic region was meager (Fig. 3B).
b-Catenin Regulates Lrh-1 Expression Through Tcf3
b-catenin promotes target gene expression by interacting with
members of the LEF/TCF family of transcription factors.
Under nonstimulatory conditions, LEF/TCF factors mediate
transcriptional repression of Wnt target genes through an
interaction with Groucho [16]. The LEF/TCF factor, Tcf3,
was previously reported to directly repress Nanog gene
expression in ESC, and genetic ablation or knockdown of
Tcf3 suggested that it acts as a limiter of self-renewal by
counteracting effects of Nanog and Oct4 [43, 44]. Others
report that Tcf3 is an integral member of the Oct4/Sox2/
Nanog pluripotency axis [45, 46]. Considering these ﬁndings,
we sought to determine if b-catenin regulation of Lrh-1
occurred through Tcf3. The Lrh-1 reporters described in Fig-
ure 2D were transfected into undifferentiated Tcf3
-/- ESC with
an increasing concentration of Tcf3 expression vector [39]. As
reported previously, the Lrh-1 FL promoter exhibited basal
activity, however, the 1.4-kb ES-speciﬁc promoter yielded
high promoter activity that was repressed by Tcf3 in a con-
centration-dependent manner (Fig. 3C). When serial trunca-
tions of this promoter were assayed, the ability of Tcf3 to
repress activity was diminished on loss of the putative LEF/
TCF sites in each promoter, implying that they are necessary
for mediating Tcf3 repression of Lrh-1 in vitro (Fig. 3C).
ChIP of Tcf3 exhibited enrichment at Ts(ES)-1 and
Ts(ES)-2 in the Lrh-1 ES-speciﬁc promoter, but enrichment
was not observed in the FL-promoter (Fig. 3D). Tcf3 enrich-
ment at the Oct4 and GAPDH promoters was evaluated and
served as positive and negative controls for the ChIP assay
[45, 46]. Importantly, b-catenin and Tcf3 exhibit signiﬁcant
enrichment at the Lrh-1 ES-promoter, indicating a likely part-
nership between the two in the regulation of Lrh-1.
Lrh-1
-/- ESCs Express Decreased Levels of Oct4 and
Nanog
If Lrh-1 is indeed a novel target gene of b-catenin in vivo,
then we would expect the Lrh-1
-/- ESC to recapitulate the
defect in pluripotency gene expression observed in the b-cate-
nin
-/- ESC [12]. Wild-type and Lrh-1
-/- ESC were differenti-
ated as embryoid bodies or by RA-mediated differentiation
under the same conditions reported in Figure 1. As reported
for the b-catenin
-/- ESC, the Lrh-1
-/- ESC express signiﬁcantly
decreased levels of Oct4 and Nanog, while expressing similar
levels of b-catenin (Fig. 4A, Supporting Information Fig. 4).
This defect was also apparent at the protein level in which
Oct4 and Nanog underwent more rapid silencing in the Lrh-
1
-/- ESC (Fig. 4B). Together, the Lrh-1
-/- ESC mirror the
defect in pluripotency gene expression observed in the b-cate-
nin
-/- ESC. In contrast to the b-catenin
-/- ESC, the Lrh-1
-/-
ESC readily form teratomas composed of tissues of all three
germ layers (Fig. 4C). Additionally, Lrh-1
-/- ESC can express
markers of all three germ lineages on embryoid body differen-
tiation (Supporting Information Fig. 5). In light of this
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catenin-null mice may go well beyond the misregulation of
Lrh-1 alone.
Stabilizing b-Catenin Promotes Oct4 Expression in
an Lrh-1-Dependent Manner
To explore whether Lrh-1 misexpression could account for
the decreased pluripotency gene expression observed in the b-
catenin
-/- ESC, we assayed Oct4 expression in our cell lines
after stimulating Wnt signaling with BIO or Wnt3a in the ab-
sence of LIF. BIO treatment of wt ESC caused a signiﬁcant
induction of Oct4 and was able to maintain undifferentiated
levels of expression out to 5 days of treatment (Fig. 4D, upper
graph). Strikingly, the BIO-mediated induction of Oct4, and
subsequent maintenance of expression was observed to be
both b-catenin and Lrh-1-dependent (Fig. 4D, middle and
Figure 3. b-catenin/Tcf3 directly regulates Lrh-1 expression in mESC. (A): Genomic map of the Lrh-1 regulatory regions including location
and evolutionary conservation of putative LEF/TCF sites. The FL Lrh-1 promoter contains the putative LEF/TCF sites named: Ts(FL)-1 and
Ts(FL)-2, and the ES-speciﬁc promoter contains: Ts(ES)-1 and Ts(ES)-2. (B): Chromatin-IP (ChIP) of b-catenin. Wt and b-catenin
-/- ESC were
treated with vehicle or BIO for 6 hours and RA for 2 days on ﬁxation for ChIP. TCF sites: Ts(FL)-1 and Ts(FL)-2 (within the Lrh-1 FL pro-
moter), and Ts(ES)-1 and Ts(ES)-2 (within the Lrh-1 ES-speciﬁc promoter) were examined for b-catenin binding. A previously reported TCF site
in the Axin2 promoter served as the positive control, and an Lrh-1 intronic region served as the negative control. Binding in wt cells was normal-
ized to the background observed in the b-catenin
-/- ESC. (C): Transient transfection of undifferentiated Tcf3
-/- ESC with luciferase reporters for
the Lrh-1 FL promoter, the ES promoter, and truncations of the ES promoter, in combination with increasing concentrations (0–800 ng) of Tcf3
expression vector. (D): ChIP of Tcf3. Undifferentiated wt ESC were cultured in the presence of leukemia inhibitory factor on ﬁxation for ChIP.
Tcf3 binding was investigated at putative TCF sites: Ts(FL)-1, Ts(FL)-2, Ts(ES)-1, and Ts(ES)-2 in the Lrh-1 promoters. The Oct4 promoter
served as positive control, and the GAPDH promoter served as a negative control for the assay. All treatments were normalized to input DNA
and background levels for immunoprecipitation were determined by IgG precipitation. Abbreviations: BIO, 6-bromoindirubin-30-oxime; FL, full-
length promoter; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; chromatin IP, chromatin immunoprecipitation; RA, retinoic acid; RLU,
relative light unit; TCF, T-cell factor.
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sufﬁcient to maintain Oct4 protein levels in long-term culture,
which is consistent with previous reports [7] (Supporting In-
formation Fig. 6). Treating the ES cell lines with recombinant
Wnt3a yielded approximately a twofold induction in Oct4,
that was entirely b-catenin-dependent (Fig. 4E). Wnt3a
yielded a modest induction of Oct4 in the Lrh-1
-/- ESC, how-
ever, it was signiﬁcantly less than that observed in wt ESC,
suggesting that full induction of Oct4 requires Lrh-1 and b-
catenin (Fig. 4F).
Lrh-1 Regulates the Tbx3/Nanog Signaling Axis that
Drives Self-Renewal
To investigate the signiﬁcance of b-catenin regulation of Lrh-
1 in ESC, we wanted to determine if Lrh-1 affects the Stat3/
Klf4/Sox2 or Tbx3/Nanog signaling axes. In culture, LIF sup-
ports mESC self-renewal by promoting two parallel signaling
axes [6]. One axis includes activation of Stat3, causing induc-
tion of Klf4, which in turn regulates expression of Sox2,
whereas the parallel axis comprises activation of PI3K, caus-
ing induction of Tbx3, and subsequent regulation of Nanog
expression. Intriguingly, LIF is not required in vivo to main-
tain pluripotency suggesting alternate mechanisms may pro-
mote these signaling axes [9]. To investigate if b-catenin reg-
ulation of Lrh-1 has a role in regulating these signaling axes,
wt ESCs were treated with BIO to determine if stimulating
Wnt signaling is sufﬁcient to induce expression of these fac-
tors. Lrh-1, Oct4, Nanog, and Tbx3, all exhibit signiﬁcant
induction on BIO treatment in wt ESC, and are repressed on
differentiation with RA (Fig. 5A). Importantly, the induction
Figure 4. b-catenin regulation of Lrh-1 underlies the effects on Oct4 expression. (A): qRT-PCR analysis of Oct4, Nanog, Lrh-1, and b-catenin
expression in wt and Lrh-1
-/- ESC on embryoid body differentiation. *, p < .05; ***, p < .001. (B): Western Blot analysis of Oct4, Nanog, Lrh-
1, and b-catenin expression in wt and Lrh-1
-/- ESC on differentiation with retinoic acid. b-actin was probed as a loading control. (C): Histological
staining of a teratoma generated by Lrh-1
-/- ESC. Endoderm tissues (epithelium, glandular endoderm), mesoderm tissues (muscle, adipose, carti-
lage), and ectoderm tissues (neural epithelium, epidermis) were identiﬁed. (D): qRT-PCR analysis of Oct4 expression on treatment with BIO. Wt
(upper graph), b-catenin
-/- (middle graph), and Lrh-1
-/- ESC (lower graph) were treated with BIO or DMSO vehicle in the absence of leukemia
inhibitory factor (LIF). **, p < .01. (E): qRT-PCR analysis of Oct4 expression on treatment of wt and b-catenin
-/- ESC with recombinant Wnt3a
for 24 hours in the absence of LIF. **, p < .01. (F): qRT-PCR analysis of Oct4 expression on treatment of wt and Lrh-1
-/- ESC with recombinant
Wnt3a as described in (E). *, p < .05; **, p < .01. Abbreviations: BIO, 6-bromoindirubin-30-oxime; DMSO, dimethyl sulfoxide; qRT-PCR,
quantitative reverse transcribed-polymerase chain reaction; wt ES, wild type embryonic stem.
1800 Canonical Wnt Regulation of Lrh-1Figure 5. Lrh-1 directly regulates Oct4, Nanog, and Tbx3 expression in mESC. (A): Western blot analysis of b-catenin, Lrh-1, Oct4, Nanog,
Tbx3, and Klf4 expression on inducing b-catenin stability with BIO or differentiated the ESC with RA. Wild-type, b-catenin
-/-, and Lrh-1
-/- ESC
were treated with DMSO vehicle or BIO for 12 hours or RA for 2 days. All treatments were performed in the absence of leukemia inhibitory fac-
tor. b-actin was probed as a loading control. (B): Schematic depicting the targeting vector used to generate Lrh-1 stable overexpressing ESC.
Myc-tagged mLrh-1(ES)-IRES-neo expression is driven by the pEF1a promoter. (C): Western blot analysis of b-catenin, Lrh-1, Oct4, Nanog,
Tbx3, and Klf4 expression in undifferentiated wt, Lrh-1
-/-, and Lrh-1
þ/þ(myc-Lrh-1) stably expressing ESC. b-actin was probed as a loading con-
trol. (D): Direct regulation of Oct4 by Lrh-1. ChIP experiment exhibiting direct binding of Lrh-1 to the PP and PE of the Oct4 promoter. Binding
in wt cells was normalized to the background observed in the Lrh-1
-/- ES cells. An intronic region was examined as a negative control for bind-
ing. (E): Direct regulation of Nanog by Lrh-1. Experiment and analysis was performed as in (D). Enrichment of Lrh-1 binding is observed in the
5 kb promoter, however, enrichment was not observed at consensus sites in the 30UTR. (F): Direct regulation of Tbx3 by Lrh-1. Experiment and
analysis was performed as in (D). Enrichment of Lrh-1 binding is observed within the enhancer region of Tbx3.( G): Lrh-1 ChIP targeting the
Klf4 promoter. Experiment and analysis was performed as in (D). Enrichment of Lrh-1 was not observed within the Klf4 promoter despite the
presence of two consensus sites in the Klf4 promoter. Abbreviations: BIO, 6-bromoindirubin-30-oxime; ChIP, chromatin Immunoprecipitation;
DMSO, dimethyl sulfoxide; EF-1a, elongation factor -1a; IRES, internal ribosome entry site; PE, proximal enhancer; PP, proximal promoter; RA,
retinoic acid; wt mES, wild type mouse embryonic stem.of these factors is both b-catenin-dependent and Lrh-1-de-
pendent because neither of the mutant cell line exhibited a
response to BIO. In contrast, BIO was ineffective at inducing
expression of Klf4 in wt and mutant ESC (Fig. 5A).
To support the pharmacological data, we incorporated a
genetic approach by stably overexpressing a myc-tagged
ES isoform of Lrh-1 in a wt mESC [33] (Fig. 5B). Overex-
pression of Lrh-1 results in a considerable induction of Oct4,
Nanog, and Tbx3 expression above the levels observed in wt
ESC (Fig. 5C). Additionally, these factors all exhibit
decreased expression in Lrh-1
-/- ESC suggesting that Lrh-1 is
required to maintain wt levels of expression. Consistent with
BIO treatment, Klf4 expression is nonresponsive to either
Lrh-1 ablation or overexpression. ChIP of Lrh-1 was per-
formed to determine whether Lrh-1 regulated Tbx3 and Nanog
expression directly. Consistent with our previous ﬁndings,
Lrh-1 enrichment was observed at the Oct4 PP and PE in
ESC [12] (Fig. 5D). Lrh-1 was also enriched at a response
element in the Nanog promoter (Fig. 5E) and in the Tbx3
enhancer region (Fig. 5F). Consistent with the previous data,
Lrh-1 was not enriched at the Klf4 locus despite two nearly
perfect consensus sites within the promoter (Fig. 5G). These
data suggest that Lrh-1 directly regulates Tbx3, Nanog, and
Oct4 expression in undifferentiated ESCs, and thereby selec-
tively promotes the Tbx3/Nanog pluripotency axis.
Ectopic Expression of Lrh-1 Restores Oct4/Nanog
Gene Expression in b-Catenin
-/- ESC
To further substantiate our hypothesis that misregulation of
Lrh-1 in b-catenin
-/- ESC is in part causing the defect in plu-
ripotency gene expression, Lrh-1 was stably expressed in a b-
catenin
-/- ESC as described in (Fig. 5B), in an attempt to
restore wt levels of pluripotency gene expression (Supporting
Information Fig. 7). The stable clone, b-catenin
-/- myc-Lrh-
1(B2), expressed Lrh-1 at levels fourfold higher than that
observed in undifferentiated wt cells (Fig. 6A). Importantly,
overexpression was able to restore Oct4 expression, as well as
prolong expression during RA differentiation (Fig. 6B). Simi-
larly, Nanog expression was restored to wt levels in undiffer-
entiated cells (Fig. 6C). Canonical Wnt signaling was not
restored in the stable cell line, which is apparent by the ab-
sence of b-catenin expression, and conﬁrms that the observed
effects on pluripotency gene expression are speciﬁc to ectopic
Lrh-1 expression (Fig. 6D).
DISCUSSION
Self-renewal of mESC in culture is directed by LIF stimulation
of parallel signaling pathways (Stat3/Klf4/Sox2 and PI3K/
Tbx3/Nanog) that converge in the regulation of Oct4, thereby
establishing the Oct4/Sox2/Nanog autoregulatory loop [1, 6].
Intriguingly, ablation of LIF signaling in the embryo at either
the ligand or receptor level does not yield an early embryonic
phenotype, thus LIF is not required to maintain pluripotency in
vivo [8, 9]. This suggests alternate mechanisms exist to pro-
mote these two signaling axes during development.
Here, we propose a secondary pluripotency axis, namely,
canonical Wnt regulation of Lrh-1 resulting in direct regulation
of Tbx3, Nanog, and Oct4. We believe this mechanism selec-
tively promotes the PI3K/Tbx3/Nanog signaling axis so as to
counteract germ cell nuclear factor (GCNF)-mediated repres-
sion of Oct4 [47, 48]. This pathway was genetically elucidated
by proﬁling pluripotency gene expression in b-catenin
-/- and
Lrh-1
-/- ESC and determining the requirement of these factors
Figure 6. Ectopic expression of Lrh-1 restores pluripotency gene expression in b-catenin
-/- ESC. (A): qRT-PCR analysis of Lrh-1 expression in un-
differentiated wt, b-catenin
-/-, and b-catenin
-/-(myc-Lrh-1) ESC on RA-mediated differentiation. (B): qRT-PCR analysis of Oct4 expression. Treat-
ments were as described in (A). (C): qRT-PCR analysis of Nanog expression. Treatments were as described in (A). (D): qRT-PCR analysis of b-
catenin expression. Treatments were as described in (A). (E): Using genetic knockout ESC models, we have shown b-catenin-dependent regulation
of Lrh-1 mediates expression of pluripotency genes. This ﬁnding was observed by employing both molecular and pharmacological tools to stimulate
or inhibit canonical Wnt signaling in our ESC lines. b-catenin and Tcf3 exhibit signiﬁcant enrichment at the Lrh-1 ES-speciﬁc promoter suggesting
they likely partner in the direct regulation of Lrh-1 expression in the ESC. Furthermore, Lrh-1 was observed to directly regulate Oct4, Nanog, and
Tbx3 expression, but not that of Klf4. Our data suggests that canonical Wnt regulation of Lrh-1 can signiﬁcantly inﬂuence the PI3K/Tbx3/Nanog/
Oct4 signaling axis while having little effect on the parallel Stat3/Klf4/Sox2/Oct4 signaling axis that has previously been modeled by Niwa et al. [6].
b-catenin regulation of Lrh-1 may be central to regulating the former signaling axis in vivo. Abbreviations: BIO, 6-bromoindirubin-30-oxime; LIF,
leukemia inhibitory factor; qRT-PCR, quantitative reverse transcribed-polymerase chain reaction.
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various molecular and pharmacological methods (Fig. 6E). We
have identiﬁed Lrh-1 as a novel direct target gene of b-catenin
and Tcf3, and we identiﬁed Tbx3 and Nanog as direct targets of
Lrh-1. We believe the linear nature of the results, and rescue of
the b-catenin
-/- ESC by ectopic Lrh-1 expression is sufﬁcient
evidence to surmise that the decrease in pluripotency gene
expression in our mutant ESC relative to wt ESC is not due to
cell line to cell line heterogeneity alone. We present a LIF-in-
dependent mechanism in which canonical Wnt regulation of
Lrh-1 selectively promotes the PI3K/Tbx3/Nanog signaling
axis over the Stat3/Klf4/Sox2 axis, as Klf4 was not responsive
to Lrh-1 induction or overexpression. We believe this mecha-
nism is likely a physiologically relevant alternative to LIF-
mediated pluripotency, which is known to be nonessential dur-
ing early development, but rather is an evolutionary adaptation
for diapause; a physiological recess in the development of the
embryo induced by a lack of resources [9].
Previous reports have identiﬁed PI3K as a component of
the LIF signaling cascade that functions independent of Stat3
[49]. Its role in regulating ESC pluripotency was reported to
occur chieﬂy through GSK3 inhibition and induction of
Nanog [50]. Though PI3K is known to promote b-catenin sta-
bility through GSK3 inhibition, the authors questioned the im-
portance of b-catenin as little nuclear translocation was
observed. In light of the b-catenin-dependent roles reported
here, it is of future interest to determine the role of PI3K
using our genetic models.
Tcf3 is reported to play an unconventional role in media-
ting the effects of the primary pluripotency axis by forming a
complex with Oct4, Sox2, and Nanog [45, 46]. Surprisingly, a
genome-wide binding assay performed for Tcf3 did not iden-
tify Lrh-1 as a target gene [45]. One possibility is that the
antibody used, or conditions established, may favor immuno-
precipitation of a Tcf3/Oct4/Sox2/Nanog complex over a
Tcf3/b-catenin complex. Tcf3
-/- ESC exhibit increased and
prolonged expression of Nanog and Lrh-1 during ESC differ-
entiation [43]. This phenotype is due to loss of Tcf3-mediated
repression, and implies that Lrh-1 is a target of Tcf3 in ESC.
Recent studies have described a ‘‘ground state’’ to ESC plu-
ripotency, concluding that ESC can self-renew independent of
growth factors and cytokines when differentiation cues are
absent, thus, ESC have an innate program directing self-
renewal [7]. Whether canonical Wnt regulation of Lrh-1 plays
a role in promoting ground state pluripotency is unknown,
however, GSK3 inhibition is essential in driving ground state
pluripotency both in ESC culture and in reprogramming [7,
51]. Alternatively, canonical Wnt regulation of Lrh-1 may be a
signature of a different pluripotent cell fate such as the epi-
stem cell. This is supported by the fact that mutant ESC lines
for b-catenin, Lrh-1, and Nanog have each been derived and
can self-renew indeﬁnitely in culture, however, in the case of
Nanog, its expression is required to establish the pluripotent
epiblast [51, 52]. It is of future interest to investigate this sig-
naling axis in pluripotent cell types derived at developmentally
later stages. A Wnt driven mechanism promoting pluripotency
gene expression, could allow for a more acute spatial and tem-
poral response to ensure the proper balance in expression.
It is also of interest to see to what degree the b-catenin/Lrh-
1 pathway can inﬂuence the emerging ﬁeld of somatic cell
reprogramming. iPSCs hold a great deal of promise for future
therapeutic applications, however, caveats exist, such as the ef-
ﬁciency of reprogramming and their safety in application.
Recently, another group identiﬁed Lrh-1 as being sufﬁcient to
replace Oct4 during viral-mediated reprogramming [53]. Others
report that stimulation of the canonical Wnt signaling pathway
with recombinant Wnt3a promotes the reprogramming of so-
matic cells in the absence of c-Myc, thereby circumventing a
major criticism of iPS generation [54]. The discovery of nonge-
netic approaches to improve reprogramming, such as through
the use of small molecules and signaling peptides that can be
added exogenously is paramount for the ﬁeld.
The intricate nature of the Wnt signaling pathway makes
it amenable to small molecule manipulation. Many known
modulators of Wnt signaling have been characterized, and
may hold potential not just in promoting somatic cell reprog-
ramming, but perhaps in directing differentiation into speciﬁc
lineages as well [55]. Additionally, research is currently
underway to identify a physiological ligand for Lrh-1, as well
as develop synthetic molecules that may modulate Lrh-1 tran-
scriptional activity. The development and characterization of
such modulators may prove beneﬁcial in a host of ESC appli-
cations and in cancer models as well.
CONCLUSION
Here, we present evidence that canonical Wnt/b-catenin path-
way regulates Lrh-1 during ESC self-renewal thereby com-
prising a secondary pluripotency axis in the promotion of
Oct4, Nanog, and Tbx3 gene expression. We base this ﬁnding
on the incorporation of genetic, pharmacological, and molecu-
lar studies that are described herein. Furthermore, Lrh-1 was
identiﬁed as novel target gene of both b-catenin and Tcf3,
indicating they likely partner in regulating Lrh-1 expression
in the ESC. We believe this pathway to be signiﬁcant as it
provides an alternate mechanism to LIF-mediated pluripo-
tency, which is known to be dispensable in vivo [8, 9], and
may prove amenable to small molecule applications to direct
reprogramming or differentiation.
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